Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Farmers Insurance
Dow
Cerilliant
Queensland Health
Cipla
Fish and Richardson
Federal Trade Commission
Chinese Patent Office

Generated: May 20, 2018

DrugPatentWatch Database Preview

Details for Patent: 6,353,029

« Back to Dashboard

Which drugs does patent 6,353,029 protect, and when does it expire?

Patent 6,353,029 protects SOLAGE and is included in one NDA.

This patent has thirteen patent family members in twelve countries.
Summary for Patent: 6,353,029
Title: Storage stable tretinoin and 4-hydroxyanisole containing topical composition
Abstract:A long-term storage stable tretinoin and 4-hydroxyanisole composition contains low molecular weight polyethylene glycol, antioxidant, a chelating agent, lower alkanol and water. The chelating agent provides at least two of the functions of oxygen scavaging, free radical chain terminating and reducing. The composition has a pH of 2.5 to 5 and a water content of at least 12%.
Inventor(s): Parab; Prakash V. (Plainsboro, NJ)
Assignee: Bristol-Myers Squibb Company (New York, NY)
Application Number:09/644,912
Patent Claim Types:
see list of patent claims
Formulation;

Drugs Protected by US Patent 6,353,029

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Aqua Pharms SOLAGE mequinol; tretinoin SOLUTION;TOPICAL 020922-001 Dec 10, 1999 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Family Members for US Patent 6,353,029

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
World Intellectual Property Organization (WIPO) 0215851 ➤ Sign Up
Russian Federation 2270002 ➤ Sign Up
Poland 365681 ➤ Sign Up
Mexico PA03001552 ➤ Sign Up
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
US Department of Justice
Johnson and Johnson
Julphar
Teva
Argus Health
Farmers Insurance
AstraZeneca
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.